Autopsy report · NCT01985022
Changing Developmental Trajectories Through Early Treatment
Cause of deathStaffing, sites or logistics
“Participant enrollment was hindered by the COVID-19 pandemic and the study was ultimately terminated.”
Life of this trial
- Registered 6 months after it had already started.
- Ran for about 6 years 6 months before it stopped.
- 33 participants enrolled.
- Results were posted on the registry 3 years 6 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Emory University
- Sponsor type
- University, hospital or other
- Conditions
- Autism Spectrum Disorders
- Interventions
- Group-ESI; Individual-ESI
- Participants
- 33
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Oral Immunotherapy for Desensitization in Children, Adolescents, and Young Adults With Hen Egg Allergy
“The study was prematurely terminated by the Sponsor based on difficulties in meeting enrollment goals, especially during the COVID-19 pandemic, and not for reasons relating to any concerns regarding quality, safety, or efficacy.” - Treatment Resistance Following Anti-cancer Therapies
“Study terminated due to lack of enrollment that has been compounded by the global COVID-19 pandemic. There were no safety and/or efficacy concerns involved in the decision to stop enrollment.” - Observational Study of Fostamatinib as Second Line Therapy in Adult Patients With Immune Thrombocytopenia (ITP) and Insufficient Response to a Prior Therapy
“met minimum enrollment goal, however, enrollment was slow due to the pandemic, therefore, the study was terminated” - Griffithsin-based Rectal Microbicide for PREvention of Viral ENTry (PREVENT)
“Due to the COVID-19 pandemic, study enrollment has been prematurely terminated.” - Evaluating Emetine for Viral Outbreaks (EVOLVE)
“The study was terminated due to insufficient participant enrollment resulting from a lower-than-expected number of COVID-19 cases”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.